1 Min Read
Feb 21 (Reuters) - Luye Pharma Group Ltd:
* FDA AGREES TO WAIVE PEDIATRIC CLINICAL TRIALS OF SCHIZOPHRENIA DRUG LY03004
* FDA’S DECISION WILL SIGNIFICANTLY REDUCE RESEARCH AND DEVELOPMENT COST Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.